Clinical improvement after treatment with anti-IgE antibody is associated with reduced frequencies of IFN-gamma-, IL-10-and IL-31-secreting T cells in patients with chronic spontaneous urticaria - Research portal of Justus Liebig University Giessen:

Meeting Abstract

Clinical improvement after treatment with anti-IgE antibody is associated with reduced frequencies of IFN-gamma-, IL-10-and IL-31-secreting T cells in patients with chronic spontaneous urticaria

Authors list: Rauber, M. M.; Pickert, J.; Holiangu, L.; Moebs, C.; Pfuetzner, W.

Publication year: 2018

Pages: E70-E70

Journal: Experimental Dermatology

Volume number: 27

Issue number: 3

ISSN: 0906-6705

eISSN: 1600-0625

Conference: 45th Annual Meeting of the Arbeitsgemeinscha-Dermatologische-Forschung (ADF)

Publisher: Wiley

Citation Styles

Harvard Citation style: Rauber, M., Pickert, J., Holiangu, L., Moebs, C. and Pfuetzner, W. (2018) Clinical improvement after treatment with anti-IgE antibody is associated with reduced frequencies of IFN-gamma-, IL-10-and IL-31-secreting T cells in patients with chronic spontaneous urticaria, Experimental Dermatology, 27(3), p. E70

APA Citation style: Rauber, M., Pickert, J., Holiangu, L., Moebs, C., & Pfuetzner, W. (2018). Clinical improvement after treatment with anti-IgE antibody is associated with reduced frequencies of IFN-gamma-, IL-10-and IL-31-secreting T cells in patients with chronic spontaneous urticaria. Experimental Dermatology. 27(3), E70.